Presentation Information

[O2-03E]At the Interface of Epidemiology, Vaccine Development, and Public Health Practice: Elucidating SFTS Transmission Pathways and Quantifying Risk Groups to Inform Decision-Making

*Laura Skrip1,2,3 (1. Department of Infectious Disease Epidemiology and Dynamics, Institute of Tropical Medicine, Nagasaki University (Japan), 2. School of Tropical Medicine and Global Health, Nagasaki University (Japan), 3. London School of Hygiene & Tropical Medicine (UK))

Login required to view

Login is required to view some content.

Comment

To browse or post comments, you must log in.Log in